PMS43 GOLIMUMAB, A HUMAN ANTI-TNF-ALPHA MONOCLONAL ANTIBODY, SIGNIFICANTLY REDUCES TIME LOST FROM WORK FOR PATIENTS WITH RHEUMATOID ARTHRITIS- POOLED RESULTS FROMTHREE PHASE 3 STUDIES
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66813-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)66813-1/fulltext
Title :
PMS43 GOLIMUMAB, A HUMAN ANTI-TNF-ALPHA MONOCLONAL ANTIBODY, SIGNIFICANTLY REDUCES TIME LOST FROM WORK FOR PATIENTS WITH RHEUMATOID ARTHRITIS- POOLED RESULTS FROMTHREE PHASE 3 STUDIES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66813-1&doi=10.1016/S1098-3015(10)66813-1
First page :
Section Title :
Open access? :
No
Section Order :
648